Embolic brain infarction in nonrheumatic atrial fibrillation: A clinicopathologic study in the elderly

Neurology

Volumn 48, Issue 6, 1997, Pages 1593-1597

  Yamanouchi, H ^a   Nagura, H ^a   Mizutani, T ^b   Matsushita, S ^a   Esaki, Y ^a  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; AUTOPSY; BRAIN ATHEROSCLEROSIS; BRAIN EMBOLISM; BRAIN INFARCTION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030791197     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.6.1593     Document Type: Article

References (28)

1. Kuramoto K, Matsushita S, Yamanouchi H. Atrial fibrillation as a cause of myocardial and cerebral infarctions. Jpn Circ J 1984;48:67-74.
2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. The Framingham Study. N Engl J Med 1982;306:1018-1022.
3. Caplan LR, Hier DB, D'Cruz I. Cerebral embolism in the Michael Reese Stroke Registry. Stroke 1983;14:530-537.
4. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomized trial. Stroke 1983;14:668-676.
5. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1986;43:71-84.
6. Mohr JP, Caplan LR, Melski JW, et al. The Harvard cooperative stroke registry: a prospective registry. Neurology 1978;28: 754-762.
7. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: The Framingham Study. Stroke 1983;14:664-667.
8. Cerebral Embolism Task Force. Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. Arch Neurol 1989;46:727-743.
9. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561-1564.
10. Kempster PA, Gerraty RP, Gates PC. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. Stroke 1988;19:955-957.
11. Petersen P, Madsen EB, Brun B, Pedersen F, Gyldensted C, Bovsen G. Silent cerebral infarction in chronic atrial fibrillation. Stroke 1987;18:1098-1100.
12. Feinberg WM, Seeger JF, Carmody RF, Anderson DC, Hart RG, Pearce LA. Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. Arch Intern Med 1990;150:2340-2344.
13. Yamanouchi H, Nagura H, Matsushita H, Mizutani H. Symptomatic and asymptomatic cerebral infarctions with nonrheumatic atrial fibrillation. An autopsy study in the elderly (in Japanese with an English abstract). Shinkeinaika 1994;41: 575-580.
14. National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21:637-676.
15. Fisher CM. Reducing risks of cerebral embolism. Geriatrics 1979;34:59-66.
16. Hinton RC, Kistler JP, Fallon JT, Friedlich AL, Fisher CM. Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 1977;40:509-513.
17. Sherman DG, Goldman L, Whiting RB, Jurgensen K, Kaste M, Easton JD. Thromboembolism in patients with atrial fibrillation. Arch Neurol 1984;41:708-710.
18. Yamanouchi H, Shimada H, Kuramoto K. Subtypes and proportions of cerebrovascular disease in an autopsy series in a Japanese geriatric hospital. Klin Wochenschr 1990;68:1173-1177.
19. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978;28:973-977.
20. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1989;1:175-179.
21. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Final results. Circulation 1991;84:527-539.
22. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
23. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992;327:1406-1412.
24. Kase CS, Wolf PA, Chodosh EH, et al. Prevalence of silent stroke in patients presenting with initial stroke: The Framingham Study. Stroke 1989;20:850-852.
25. Jørgensen HS, Nakayama H, Raaschou HO, Gam J, Olsen TS. Silent infarction in acute stroke patients. Prevalence, localization, risk factors, and clinical significance: the Copenhagen Stroke Study. Stroke 1994;25:97-104.
26. Ricci S, Celani MG, La Rosa F, Righetti E, Duca E, Caputo N. Silent brain infarctions in patients with first-ever stroke. A community-based study in Umbria, Italy. Stroke 1993;24:647-651.
27. Tohgi H, Mochizuki H, Yamanouchi H, et al. A comparison between the computed tomogram and the neuropathological findings in cerebrovascular disease. J Neurol 1981;224:211-220.
28. Shinkawa A, Ueda K, Kiyohara Y, et al. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke 1995;26:380-385.